BioSight
Companies
Tonix Pharmaceuticals Holding Corp. logo

TNXP

NASDAQBERKELEY HEIGHTS, NJ
Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system disorders, immunology, infectious diseases, and rare diseases. The company's commercial products include TONMYA, a centrally acting non-opioid analgesic small molecule approved for fibromyalgia in adults, as well as two FDA-approved migraine products: Zembrace SymTouch and Tosymra, both sumatriptan formulations. Tonix maintains a diversified pipeline of development and discovery-stage candidates alongside its commercial platform capabilities in sales, marketing, market access, and distribution.

Price history not yet available for TNXP.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar